OBJECTIVES: GCA is characterized by arterial remodelling driven by inflammation. IL-22 is an attractive cytokine which acts at the crosstalk between immune and stromal cells. We hypothesized that IL-22 might be induced in GCA and might be involved in disease pathogenesis. METHODS: Patients subjected to temporal artery biopsies (TABs) naïve from therapy were enrolled: 27 biopsy-proven GCA, 8 biopsy-negative GCA, 21 biopsy-negative non-GCA patients. Expression of IL-22 was determined in TABs by immunohystochemistry, in plasma by ELISA, in peripheral blood mononuclear cells by real-time PCR and flow cytometry. Effects of IL-22 on viability and gene expression of primary cultures obtained from TABs were also evaluated. RESULTS: Inflamed TABs from GCA patients showed a higher expression of IL-22 and IL-22 specific receptor subunit (IL-22R1) than non-inflamed TABs. IL-22 was expressed in infiltrating immune cells and spindle shaped cells, IL-22R1 was expressed in endothelial cells. Patients with biopsy-proven GCA showed increased levels of IL-22 in plasma than patients with biopsy-negative GCA, without GCA and healthy subjects. Peripheral blood mononuclear cells from GCA patients expressed higher IL-22 transcript than healthy subjects. After stimulation in vitro with phorbol 12-myristate 13-acetate and ionomycin, the frequencies of Th22 and IL-22+ CD4+ lymphocytes were similar between patients with and without GCA. Treatment with IL-22 of primary cultures obtained from TABs increased cell viability under stress conditions and expression of B-cell activating factor. CONCLUSION: IL-22 is increased in patients with GCA and affects viability and gene expression of arterial cells, supporting a potential role in disease pathogenesis.

Increased expression of interleukin-22 in patients with giant cell arteritis / Zerbini, Alessandro; Muratore, Francesco; Boiardi, Luigi; Ciccia, Francesco; Bonacini, Martina; Belloni, Lucia; Cavazza, Alberto; Cimino, Luca; Moramarco, Antonio; Alessandro, Riccardo; Rizzo, Aroldo; Parmeggiani, Maria; Salvarani, Carlo; Croci, Stefania. - In: RHEUMATOLOGY. - ISSN 1462-0332. - 57:1(2018), pp. 64-72. [10.1093/rheumatology/kex334]

Increased expression of interleukin-22 in patients with giant cell arteritis

Muratore, Francesco;Cimino, Luca;Salvarani, Carlo;
2018

Abstract

OBJECTIVES: GCA is characterized by arterial remodelling driven by inflammation. IL-22 is an attractive cytokine which acts at the crosstalk between immune and stromal cells. We hypothesized that IL-22 might be induced in GCA and might be involved in disease pathogenesis. METHODS: Patients subjected to temporal artery biopsies (TABs) naïve from therapy were enrolled: 27 biopsy-proven GCA, 8 biopsy-negative GCA, 21 biopsy-negative non-GCA patients. Expression of IL-22 was determined in TABs by immunohystochemistry, in plasma by ELISA, in peripheral blood mononuclear cells by real-time PCR and flow cytometry. Effects of IL-22 on viability and gene expression of primary cultures obtained from TABs were also evaluated. RESULTS: Inflamed TABs from GCA patients showed a higher expression of IL-22 and IL-22 specific receptor subunit (IL-22R1) than non-inflamed TABs. IL-22 was expressed in infiltrating immune cells and spindle shaped cells, IL-22R1 was expressed in endothelial cells. Patients with biopsy-proven GCA showed increased levels of IL-22 in plasma than patients with biopsy-negative GCA, without GCA and healthy subjects. Peripheral blood mononuclear cells from GCA patients expressed higher IL-22 transcript than healthy subjects. After stimulation in vitro with phorbol 12-myristate 13-acetate and ionomycin, the frequencies of Th22 and IL-22+ CD4+ lymphocytes were similar between patients with and without GCA. Treatment with IL-22 of primary cultures obtained from TABs increased cell viability under stress conditions and expression of B-cell activating factor. CONCLUSION: IL-22 is increased in patients with GCA and affects viability and gene expression of arterial cells, supporting a potential role in disease pathogenesis.
2018
57
1
64
72
Increased expression of interleukin-22 in patients with giant cell arteritis / Zerbini, Alessandro; Muratore, Francesco; Boiardi, Luigi; Ciccia, Francesco; Bonacini, Martina; Belloni, Lucia; Cavazza, Alberto; Cimino, Luca; Moramarco, Antonio; Alessandro, Riccardo; Rizzo, Aroldo; Parmeggiani, Maria; Salvarani, Carlo; Croci, Stefania. - In: RHEUMATOLOGY. - ISSN 1462-0332. - 57:1(2018), pp. 64-72. [10.1093/rheumatology/kex334]
Zerbini, Alessandro; Muratore, Francesco; Boiardi, Luigi; Ciccia, Francesco; Bonacini, Martina; Belloni, Lucia; Cavazza, Alberto; Cimino, Luca; Moramarco, Antonio; Alessandro, Riccardo; Rizzo, Aroldo; Parmeggiani, Maria; Salvarani, Carlo; Croci, Stefania
File in questo prodotto:
File Dimensione Formato  
senza_titolo.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 567.62 kB
Formato Adobe PDF
567.62 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1155249
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact